Sentrx to Exhibit at 19th Annual Partnerships in Clinical Trials
LITTLE FALLS, N.J.--(BUSINESS WIRE)--Mar 30, 2010 - Sentrx, the leading provider of drug safety services to the life science industry, announced today it will exhibit at the 19th Annual Partnerships in Clinical Trials at booth #562 on April 12-14, 2010 in Orlando, FL.
Sentrx will be providing information about its new “CROplus” solution for clinical research organizations seeking to add or bolster pharmacovigilance capabilities. “Drug safety is rapidly migrating from its traditional view as a pure compliance function into a primary value driver,” said Charles T. Saldarini, CEO of Sentrx. “CROs working in close partnership with their sponsors may want to benefit from this trend by including a world class drug safety capability. Our new solution for CROs provides two decades of pharmacovigilance experience, our safety technology capabilities as well as our extensive expertise in adverse event management to the CRO community. These capabilities are now easily accessible to CRO partners, enabling them to help accelerate this very exciting industry shift within drug safety and adverse event management.”
Sentrx will have on hand at its exhibit several of its pharmacovigilance and drug safety experts to facilitate discussion with those CROs requiring expanded safety footprints. Michael O'Gorman, Chief Financial Officer & Vice President for Strategic Alliances, said “We are today in an excellent position to support the CRO community having reshaped our operations into a client centric structure with an absolute focus on meeting needs such as rapid safety system implementation, complete channel support and accessible expertise. The upshot for CROs partnering with Sentrx is confidence. We've been at safety for 15 years and simply have an excellence in delivering a completely integrated safety capability, implemented quickly, the confidence of great confidence.”
CROs who wish to set up needs assessments or a one on one session with Sentrx should contact Michael O'Gorman at Michael.Ogorman@sentrx.com.
Sentrx is leading the industry with a group of experts focused on drug safety and all of its critical connections to technology systems, regulatory requirements, clinical operations, medical affairs and commercial management. We design our solutions to be customized, integrated and scalable, and therefore our clients' benefit from improved efficiency, reduced cost, and greater flexibility.
Janice Scheider, 973-826-1824
Posted: March 2010